Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

[Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].

Chen DB, Wang Y, Song QJ, Shen DH.

Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):607-12. doi: 10.3760/cma.j.issn.0529-5807.2012.09.008. Chinese.

PMID:
23157829
2.

Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation.

Chen DB, Song QJ, Chen YX, Chen YH, Shen DH.

Int J Hematol. 2013 Jan;97(1):117-24. doi: 10.1007/s12185-012-1244-1. Epub 2012 Dec 20.

PMID:
23255160
3.

Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, Omar H, Martino R, Halkes C, Faraci M, Theunissen K, Kalwak K, Hubacek P, Sica S, Nozzoli C, Fagioli F, Matthes S, Diaz MA, Migliavacca M, Balduzzi A, Tomaszewska A, Camara Rde L, van Biezen A, Hoek J, Iacobelli S, Einsele H, Cesaro S; Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Clin Infect Dis. 2013 Sep;57(6):794-802. doi: 10.1093/cid/cit391. Epub 2013 Jun 13.

PMID:
23771985
4.

EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.

Hart M, Thakral B, Yohe S, Balfour HH Jr, Singh C, Spears M, McKenna RW.

Am J Surg Pathol. 2014 Nov;38(11):1522-9. doi: 10.1097/PAS.0000000000000282.

PMID:
25007145
5.

[Clinicopathologic study of post-transplant lymphoproliferative disorders].

Zhang YN, Zhou XG, Wang CZ, Wei P, Zhang SH, Zheng YY.

Zhonghua Bing Li Xue Za Zhi. 2006 Apr;35(4):209-12. Chinese.

PMID:
16776977
6.

The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis.

Yamamoto N, Nishimura N, Takeuchi M, Ito T, Yokozaki H, Hirase S, Kubokawa I, Mori T, Yanai T, Hayakawa A, Takeshima Y, Nishio H, Matsuo M, Imadome K, Iijima K.

Eur J Pediatr. 2014 Dec;173(12):1615-8. doi: 10.1007/s00431-013-2181-6. Epub 2013 Oct 30.

PMID:
24169729
7.

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

Trappe R, Oertel S, Leblond V, Mollee P, Sender M, Reinke P, Neuhaus R, Lehmkuhl H, Horst HA, Salles G, Morschhauser F, Jaccard A, Lamy T, Leithäuser M, Zimmermann H, Anagnostopoulos I, Raphael M, Riess H, Choquet S; German PTLD Study Group; European PTLD Network.

Lancet Oncol. 2012 Feb;13(2):196-206. doi: 10.1016/S1470-2045(11)70300-X. Epub 2011 Dec 13.

PMID:
22173060
8.

Post-transplant lymphoproliferative disorder--case reports of three children with kidney transplant.

Spasojević-Dimitrijeva B, Peco-Antić A, Paripović D, Kruscić D, Krstić Z, Cupić M, Cvetković M, Milosevski-Lomić G, Kostić M.

Srp Arh Celok Lek. 2014 Jan-Feb;142(1-2):83-8.

9.

Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.

Ganne V, Siddiqi N, Kamaplath B, Chang CC, Cohen EP, Bresnahan BA, Hariharan S.

Clin Transplant. 2003 Oct;17(5):417-22.

PMID:
14703923
10.

Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.

Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ.

Am J Surg Pathol. 2006 Mar;30(3):328-36.

PMID:
16538052
11.

Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment.

Chiereghin A, Bertuzzi C, Piccirilli G, Gabrielli L, Squarzoni D, Turello G, Ferioli M, Sessa M, Bonifazi F, Zanoni L, Sabattini E, Lazzarotto T.

Transpl Immunol. 2016 Feb;34:60-4. doi: 10.1016/j.trim.2015.12.002. Epub 2015 Dec 12.

PMID:
26687013
12.

[Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].

Xu FP, Liu YH, Zhuang HG, Luo DL, Li L, Zhang F, Luo XL, Du X, Li WY, Chen Q.

Zhonghua Bing Li Xue Za Zhi. 2011 Sep;40(9):616-21. Chinese.

PMID:
22177246
13.

Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients.

Berney T, Delis S, Kato T, Nishida S, Mittal NK, Madariaga J, Levi D, Nery JR, Cirocco RE, Gelman B, Ruiz P, Tzakis AG.

Transplantation. 2002 Oct 15;74(7):1000-6.

PMID:
12394845
14.

Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.

Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.

J Clin Oncol. 2009 Jul 10;27(20):3354-62. doi: 10.1200/JCO.2008.20.0857. Epub 2009 May 18.

PMID:
19451438
15.

EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.

Courville EL, Yohe S, Chou D, Nardi V, Lazaryan A, Thakral B, Nelson AC, Ferry JA, Sohani AR.

Mod Pathol. 2016 Oct;29(10):1200-11. doi: 10.1038/modpathol.2016.130. Epub 2016 Jul 22.

16.

Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.

Chan TS, Hwang YY, Gill H, Au WY, Leung AY, Tse E, Chim CS, Loong F, Kwong YL.

Clin Transplant. 2012 Sep-Oct;26(5):679-83. doi: 10.1111/j.1399-0012.2011.01593.x. Epub 2012 Feb 10.

PMID:
22324300
17.

[Clinicopathologic features of systemic EBV-positive T-cell lymphoproliferative disease of childhood].

Jin Y, Zhou XG, He LJ, Xie JL, Zheng YY, Zhang YN, Zhang SH.

Zhonghua Bing Li Xue Za Zhi. 2009 Sep;38(9):600-8. Chinese.

PMID:
20079188
18.

Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?

Ranganathan S, Webber S, Ahuja S, Jaffe R.

Pediatr Dev Pathol. 2004 Jul-Aug;7(4):348-60. Epub 2004 Jun 17.

PMID:
14564542
19.

[Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults].

Zheng XD, Zhou XG, Jin Y, Xie JL, Wei XJ, Chen SY, Mei X, Gong LP, Lü BB.

Zhonghua Bing Li Xue Za Zhi. 2011 Apr;40(4):227-34. Chinese.

PMID:
21615995
20.

Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.

Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.

Pediatr Transplant. 2009 Feb;13(1):54-62. doi: 10.1111/j.1399-3046.2008.00969.x. Epub 2008 Jun 1.

PMID:
18518912

Supplemental Content

Support Center